慢性胰腺炎综合疼痛评估工具简表(COMPAT-SF)的效度与信度检验
本研究将完整版COMPAT问卷系统缩减为5个疼痛维度的简表COMPAT-SF,在91例慢性胰腺炎患者中完成问卷,并在76例患者中检验重测信度。简表总分与生活质量、住院率、Izbicki及Brief Pain Inventory评分相关,稳定期患者组内相关系数为0.89,提示其可行、可靠且有效。
要点
- COMPAT-SF涵盖疼痛严重度、模式、诱发因素、广泛性疼痛及定性描述5个维度。
- 简表总分与生活质量及住院率相关,与Izbicki和Brief Pain Inventory评分相关(P<.0001)。
- 稳定期患者重测信度良好,组内相关系数为0.89。
核心结论
- COMPAT-SF涵盖慢性胰腺炎疼痛最相关方面,是可行、可靠且有效的疼痛评估工具,推荐用于未来试验。
研究设计与样本
- 完整版COMPAT问卷由91例患者完成,系统缩减为6个问题后合并疼痛严重度与镇痛药使用,最终保留5个疼痛维度。
- 简表信度在76例患者中通过重测研究检验,同时以Brief Pain Inventory和Izbicki疼痛问卷检验同时效度。
- 采用验证性因子分析验证聚合效度,并以生活质量和住院率检验标准效度。
主要发现
- COMPAT-SF包含疼痛严重度、疼痛模式、诱发疼痛因素、广泛性疼痛及定性疼痛描述5个维度。
- 生活质量与总分及所有疼痛维度相关(P<.05)。
- 总分、疼痛严重度、疼痛模式及诱发疼痛因素与住院率相关(P<.05)。
- 总分与Izbicki和Brief Pain Inventory评分相关(P<.0001)。
- 稳定期患者重测信度良好,组内相关系数为0.89。
关键数值与推荐
- 疼痛维度评分归一化为0-100分,计算加权总分,其中3个维度权重加倍。
临床怎么用
- COMPAT-SF可用于慢性胰腺炎患者疼痛的多维度评估,推荐在未来临床试验中使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Pain is the foremost complication to chronic pancreatitis (CP), but no validated questionnaires for assessment exist. The COMPAT questionnaire includes all relevant pain dimensions in CP, but a short form is needed to make it usable in clinical practice. METHODS: The full COMPAT questionnaire was completed by 91 patients and systematically reduced to 6 questions. Pain severity and analgesic use were merged, leaving 5 pain dimensions. The pain dimension ratings were normalized to a 0-100 scale, and the weighted total score was calculated, where 3 dimensions were weighted double. Reliability of the short form was tested in a test-retest study in 76 patients, and concurrent validity tested against the Brief Pain Inventory and Izbicki pain questionnaire. Convergent validity was verified using confirmatory factor analysis, and criterion validity tested against quality-of-life and hospitalization rates. RESULTS: The COMPAT-SF questionnaire consisted of the following pain dimensions: a) pain severity, b) pain pattern, c) factors provoking pain, d) widespread pain, and e) a qualitative pain-describing dimension. Quality of life correlated with the total score and all pain dimensions (P <.05). The total score, pain severity, pain pattern, and factors provoking pain were correlated with hospitalization rates (P <.05). The total score correlated with the Izbicki and Brief Pain Inventory scores (P <.0001). The reliability of the questionnaire in patients in a stable phase was good with an interclass correlation coefficient of 0.89. CONCLUSION: The COMPAT-SF questionnaire includes the most relevant aspects of pain in CP and is a feasible, reliable, and valid pain assessment instrument recommended to be used in future trials.
引用
- Kuhlmann L, Teo K, Olesen SS, et al. Development of the Comprehensive Pain Assessment Tool Short Form for Chronic Pancreatitis: Validity and Reliability Testing. Clin Gastroenterol Hepatol. 2021. PMID: 34089847. doi:10.1016/j.cgh.2021.05.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。